Showing results (1-10 of 7,236) with videos related to
Sort By:
Pageof 724
European Journal of Pharmacology|June 16, 1982
Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptorsB Chan, P Seeman, A Davis, et al.European Journal of Pharmacology|August 27, 1981
Assay for soluble dopamine receptors by the precipitation methodB Chan, B K Madras, A Davis, et al.Biochemical Pharmacology|April 1, 1982
Solubilized receptors for [3H]dopamine (D3 binding sites) from canine brainA Davis, B K Madras, P SeemanEuropean Journal of Pharmacology|March 26, 1982
Comparison of soluble dopamine D2-receptors from three speciesB K Madras, A Davis, P SeemanMolecular Psychiatry|October 17, 1998
Anti-hyperactivity medication: methylphenidate and amphetamineP Seeman, B K MadrasJournal of Neurochemistry|March 1, 1985
Drug potencies on partially purified brain D2 dopamine receptorsB K Madras, P SeemanEuropean Journal of Pharmacology|March 4, 1983
Partial purification of [3H]mianserin binding sitesB Chan, B K MadrasEuropean Journal of Pharmacology|September 10, 1982
[3H]Mianserin binding to solubilized membranes of frontal cortexB Chan, B K MadrasEuropean Journal of Pharmacology|March 26, 1981
Solubilization of neuroleptic/dopamine receptors of human brain striatumA Davis, B Madras, P SeemanThe Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeysM Goulet, B K MadrasPageof 724